论文部分内容阅读
目的:分析质子泵抑制剂应用情况。方法:调查长江流域6市178家医院中,对应用质子泵抑制剂的常用品种、销售金额等,并结合临床应用和国内外医药动态进行分析。结果:质子泵抑制剂的常用品种为奥美拉唑、泮托拉唑、埃索美拉唑、雷贝拉唑、兰索拉唑,2008年销售总金额分别为33218万(上海)、11733万(杭州)、8947万(南京)、6583万(武汉)、5641万(成都)、5338万(重庆);单品种用药金额居首位是奥美拉唑,其次是泮托拉唑。结论:质子泵抑制剂在长江流域6市利用前景看好。
Objective: To analyze the application of proton pump inhibitors. Methods: Of 178 hospitals in 6 cities of the Yangtze valley, the common species and sales amount of proton pump inhibitors were investigated, and the clinical application and the domestic and international medical dynamics were analyzed. Results: Commonly used varieties of proton pump inhibitors were omeprazole, pantoprazole, esomeprazole, rabeprazole and lansoprazole. The total sales in 2008 were 332.18 million (Shanghai), 11733 (Hangzhou), 89.47 million (Nanjing), 65.83 million (Wuhan), 56.41 million (Chengdu) and 53.38 million (Chongqing). The first place with single species was omeprazole, followed by pantoprazole. Conclusion: Proton pump inhibitors have a good prospect of utilization in 6 cities of the Yangtze River Basin.